Effects of rifampin on biliary lipids in humans

K. Von Bergmann, J. Fierer, H. Y I Mok, Scott M Grundy

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Because the action of rifampin induces hepatic microsomal enzymes, a study was carried out in four patients to determine whether this drug alters the composition of biliary lipids. Several different measurements were made while patients were both on and off rifampin therapy for various infective processes. These measurements included multiple determinations of lipid composition of gallbladder bile, the relative proportions of individual bile acids, and kinetics of cholic acid and chenodeoxycholic acid. In all four patients, the saturation of gallbladder bile increased during rifampin treatment, and the bile consistently became supersaturated. The relative portions of chenodeoxycholic acid and cholic acid were essentially unchanged by treatment, but total synthesis of bile acids increased in three tested patients with rifampin therapy. These results indicate that rifampin increases saturation of bile with cholesterol, but this increase is not due to a reduction in bile acid production.

Original languageEnglish (US)
Pages (from-to)342-345
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume19
Issue number2
StatePublished - 1981

Fingerprint

Rifampin
Bile
Lipids
Bile Acids and Salts
Chenodeoxycholic Acid
Cholic Acid
Gallbladder
Therapeutics
Cholesterol
Liver
Enzymes
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Von Bergmann, K., Fierer, J., Mok, H. Y. I., & Grundy, S. M. (1981). Effects of rifampin on biliary lipids in humans. Antimicrobial Agents and Chemotherapy, 19(2), 342-345.

Effects of rifampin on biliary lipids in humans. / Von Bergmann, K.; Fierer, J.; Mok, H. Y I; Grundy, Scott M.

In: Antimicrobial Agents and Chemotherapy, Vol. 19, No. 2, 1981, p. 342-345.

Research output: Contribution to journalArticle

Von Bergmann, K, Fierer, J, Mok, HYI & Grundy, SM 1981, 'Effects of rifampin on biliary lipids in humans', Antimicrobial Agents and Chemotherapy, vol. 19, no. 2, pp. 342-345.
Von Bergmann, K. ; Fierer, J. ; Mok, H. Y I ; Grundy, Scott M. / Effects of rifampin on biliary lipids in humans. In: Antimicrobial Agents and Chemotherapy. 1981 ; Vol. 19, No. 2. pp. 342-345.
@article{efee8f056f05479e8a279f6eb3f74b0b,
title = "Effects of rifampin on biliary lipids in humans",
abstract = "Because the action of rifampin induces hepatic microsomal enzymes, a study was carried out in four patients to determine whether this drug alters the composition of biliary lipids. Several different measurements were made while patients were both on and off rifampin therapy for various infective processes. These measurements included multiple determinations of lipid composition of gallbladder bile, the relative proportions of individual bile acids, and kinetics of cholic acid and chenodeoxycholic acid. In all four patients, the saturation of gallbladder bile increased during rifampin treatment, and the bile consistently became supersaturated. The relative portions of chenodeoxycholic acid and cholic acid were essentially unchanged by treatment, but total synthesis of bile acids increased in three tested patients with rifampin therapy. These results indicate that rifampin increases saturation of bile with cholesterol, but this increase is not due to a reduction in bile acid production.",
author = "{Von Bergmann}, K. and J. Fierer and Mok, {H. Y I} and Grundy, {Scott M}",
year = "1981",
language = "English (US)",
volume = "19",
pages = "342--345",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Effects of rifampin on biliary lipids in humans

AU - Von Bergmann, K.

AU - Fierer, J.

AU - Mok, H. Y I

AU - Grundy, Scott M

PY - 1981

Y1 - 1981

N2 - Because the action of rifampin induces hepatic microsomal enzymes, a study was carried out in four patients to determine whether this drug alters the composition of biliary lipids. Several different measurements were made while patients were both on and off rifampin therapy for various infective processes. These measurements included multiple determinations of lipid composition of gallbladder bile, the relative proportions of individual bile acids, and kinetics of cholic acid and chenodeoxycholic acid. In all four patients, the saturation of gallbladder bile increased during rifampin treatment, and the bile consistently became supersaturated. The relative portions of chenodeoxycholic acid and cholic acid were essentially unchanged by treatment, but total synthesis of bile acids increased in three tested patients with rifampin therapy. These results indicate that rifampin increases saturation of bile with cholesterol, but this increase is not due to a reduction in bile acid production.

AB - Because the action of rifampin induces hepatic microsomal enzymes, a study was carried out in four patients to determine whether this drug alters the composition of biliary lipids. Several different measurements were made while patients were both on and off rifampin therapy for various infective processes. These measurements included multiple determinations of lipid composition of gallbladder bile, the relative proportions of individual bile acids, and kinetics of cholic acid and chenodeoxycholic acid. In all four patients, the saturation of gallbladder bile increased during rifampin treatment, and the bile consistently became supersaturated. The relative portions of chenodeoxycholic acid and cholic acid were essentially unchanged by treatment, but total synthesis of bile acids increased in three tested patients with rifampin therapy. These results indicate that rifampin increases saturation of bile with cholesterol, but this increase is not due to a reduction in bile acid production.

UR - http://www.scopus.com/inward/record.url?scp=0019861415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019861415&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 342

EP - 345

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 2

ER -